pAY5 (mAID-EGFP-NLS piggyBac) Citations (1)

Originally described in: The auxin-inducible degron 2 technology provides sharp degradation control in yeast, mammalian cells, and mice.
Yesbolatova A, Saito Y, Kitamoto N, Makino-Itou H, Ajima R, Nakano R, Nakaoka H, Fukui K, Gamo K, Tominari Y, Takeuchi H, Saga Y, Hayashi KI, Kanemaki MT Nat Commun. 2020 Nov 11;11(1):5701. doi: 10.1038/s41467-020-19532-z. PubMed Journal

---

Articles Citing pAY5 (mAID-EGFP-NLS piggyBac)

Articles
Drug Repurposing for the Identification of Compounds with Anti-SARS-CoV-2 Capability via Multiple Targets. Yu PC, Huang CH, Kuo CJ, Liang PH, Wang LH, Pan MY, Chang SY, Chao TL, Ieong SM, Fang JT, Huang HC, Juan HF. Pharmaceutics. 2022 Jan 12;14(1):176. doi: 10.3390/pharmaceutics14010176. PubMed

If you have published an article using this material, please email us at to have your article added to this page.